Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells.
Publication
, Journal Article
Zou, L
Published in: J Clin Oncol
June 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2018
Volume
36
Issue
16
Start / End Page
1628 / 1630
Location
United States
Related Subject Headings
- Topotecan
- Synthetic Lethal Mutations
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- DNA Topoisomerases, Type I
- Cell Cycle Proteins
- Ataxia Telangiectasia Mutated Proteins
- Ataxia Telangiectasia
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Zou, L. (2018). Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells. J Clin Oncol, 36(16), 1628–1630. https://doi.org/10.1200/JCO.2017.77.1857
Zou, Lee. “Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells.” J Clin Oncol 36, no. 16 (June 1, 2018): 1628–30. https://doi.org/10.1200/JCO.2017.77.1857.
Zou L. Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells. J Clin Oncol. 2018 Jun 1;36(16):1628–30.
Zou, Lee. “Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells.” J Clin Oncol, vol. 36, no. 16, June 2018, pp. 1628–30. Pubmed, doi:10.1200/JCO.2017.77.1857.
Zou L. Ataxia Telangiectasia-Mutated and Rad3-Related Inhibition and Topoisomerase I Trapping Create a Synthetic Lethality in Cancer Cells. J Clin Oncol. 2018 Jun 1;36(16):1628–1630.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
June 1, 2018
Volume
36
Issue
16
Start / End Page
1628 / 1630
Location
United States
Related Subject Headings
- Topotecan
- Synthetic Lethal Mutations
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- DNA Topoisomerases, Type I
- Cell Cycle Proteins
- Ataxia Telangiectasia Mutated Proteins
- Ataxia Telangiectasia
- 3211 Oncology and carcinogenesis